FDA Warns of Rising Injuries From Misuse of Laughing Gas
By I. Edwards HealthDay Reporter
MONDAY, March 17, 2025 -- Health officials are warning about a rise in injuries linked to the misuse of nitrous oxide, aka laughing gas.
The gas, which is used medically as a sedative and in whipped cream cans, is now being sold in small, flavored canisters with names such as Cosmic Gas, Galaxy Gas and MassGass.
On Friday, the U.S. Food and Drug Administration (FDA) issued a warning that inhaling nitrous oxide to get high can cause dangerously low blood pressure, leading to fainting and injuries.
The administration highlighted that these products, often in colorful packaging, are available at gas stations, vape shops and online.
Nitrous oxide can briefly cut off oxygen to the brain, which can be extremely dangerous.
While manufacturers claim their products are "for culinary use only," videos of people inhaling them for recreational purposes have circulated on social media for years.
The FDA has seen a rise in reports of health issues related to nitrous oxide, and poison control centers have received more emergency calls from people collapsing after using it.
"The FDA advises consumers to not misuse or inhale nitrous oxide products," the statement said. "These products can result in serious adverse health effects, including death, when inhaled."
No federal laws restrict the sale of nitrous oxide, though some states have set age limits.
The FDA regulates it as a medical product when used by doctors, but its oversight of culinary-marketed versions remains unclear.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-18 06:00
Read more

- Weed Use During Pregnancy Triples Risk Of Behavioral Problems In Kids
- LA Wildfires Spewed Lead Into Atmosphere
- Turning Off TV Better For Heart Health Of Folks Predisposed To Diabetes
- Obinutuzumab Efficacious for Renal Response in Lupus Nephritis
- Talazoparib + Enzalutamide Tied to Improved Overall Survival in Metastatic Prostate Cancer
- Roflumilast Cream 0.05 Percent Safe, Effective in Young Children With Eczema
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions